Precision antisense
antibacterial agents may be developed into
novel antibiotics in the fight against multidrug-resistant Gram-negative
bacteria. In this study, a series of diaminobutanoic acid (DAB) dendrons
are presented as novel carriers for the delivery of antisense antibacterial
peptide nucleic acids (PNAs). The dendron–PNA conjugates targeting
the essential
acpP
gene exhibit specific antisense
antimicrobial bactericidal activity against
Escherichia
coli
and
Klebsiella pneumoniae
at one-digit micromolar concentrations, while showing low toxicity
to human cells. One compound selected from a structure–activity
relationship series showed high stability in mouse and human serum
(
t
1/2
≫ 24 h) as well as in vivo
activity against a multidrug-resistant, extended spectrum beta-lactamase-producing
E. coli
in a murine peritonitis model. The compound
was also well tolerated in mice upon
i.v.
administration
up to a dose of 20 mg/kg, and in vivo fluorescence imaging indicated
clearance via renal excretion with slight accumulation in the kidneys
and liver. Thus, DAB-based dendrons constitute a promising new chemistry
platform for development of effective delivery agents for antibacterial
drugs with possible in vivo use.